首页 | 本学科首页   官方微博 | 高级检索  
检索        

OA联合HGF治疗抗结核药物性肝损伤效果观察
引用本文:陈尊杰,谢汉彬,黄钥藩,杨仪,陈东锋.OA联合HGF治疗抗结核药物性肝损伤效果观察[J].中国热带医学,2011,11(5):530-532.
作者姓名:陈尊杰  谢汉彬  黄钥藩  杨仪  陈东锋
作者单位:汕头第三人民医院结核治疗中心,广东,汕头,515073
摘    要:目的探讨门冬氨酸鸟氨酸(OA)联合促肝细胞生长素(HGF)治疗抗结核药物性肝炎的临床疗效。方法对2006年1月~2009年12月108例确诊为抗结核药物所致药物性肝炎住院患者按确诊先后顺序随机分为治疗组(54例)和对照组(54例),治疗组给予门冬氨酸鸟氨酸和促肝细胞生长素治疗;对照组应用常规护肝治疗。结果治疗组(54例)治愈34例,显效16例,有效4例,总有效率100%;对照组(54例)治愈21例,显效16例,有效4例,无效13例,总有效率75.9%。治疗4周,2组治疗效果有显著性差异(χ2=14.779,P〈0.01)。治疗组疗效明显高于对照组,且无明显不良反应。结论门冬氨酸鸟氨酸联合促肝细胞生长素治疗抗结核药物所致药物性肝炎,能改善临床表现,有效恢复肝功能。

关 键 词:结核  药物疗效  药物性肝损伤  门冬氨酸鸟氨酸  促肝细胞生长素

Therapeutic effect of ornithine aspartate(OA) and hepatocyte growth-promoing factor(HGF) on inpatients with anti-tuberculosis-drug induced hepatitis
CHEN Zun-jie,XIE Han-bin,HUANG Yue-fan,et al..Therapeutic effect of ornithine aspartate(OA) and hepatocyte growth-promoing factor(HGF) on inpatients with anti-tuberculosis-drug induced hepatitis[J].China Tropical Medicine,2011,11(5):530-532.
Authors:CHEN Zun-jie  XIE Han-bin  HUANG Yue-fan  
Institution:CHEN Zun-jie,XIE Han-bin,HUANG Yue-fan,et al.(Shantou Municipal Third People's Hospital,Shantou 515073,Guangdong,P.R.China)
Abstract:Aim To explore the therapeutic effect of ornithine aspartate(OA) and hepatocyte growth-promoing factor on the anti-tuberculosis-drug induced hepatitis.Methods One hundred and eight inpatients suffered from hepatitis due to use of antituberculous drugs during Jan,2006 and Dec,2009 were randomly divided into treatment group and control group each consisted of 54 cases.The former was treated with ornithine aspartate(OA) and hepatocyte growth-promoing factor,but the latter was treated with routine drugs.Results...
Keywords:Tuberculosis  Lung  Drug-induced hepatitis  Ornithine aspartate  Hepatocyte growth-promoing factor  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号